US pharma giant Pfizer (NYSE: PFE) today announced that James List, has joined the company as chief internal medicine officer ...
Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine portfolio and will be responsible for advancing the ...
March 6 (Reuters) - Pfizer (PFE.N), opens new tab on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the development of its closely ...
Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment is a new chief internal medicine officer. In the role, James List ...
Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson (NYSE:JNJ) executive, as the company’s new chief internal medicine officer to boost the company's efforts in obesity drug ...
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio, Bayer’s gene therapy ...
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the development of heart disease and obesity medicines. The drugmaker said in ...
Australians pay some of the lowest medicine prices in the world for a reason: our Pharmaceutical Benefits Scheme. Here’s how ...
The 2024 list includes trial flops from the likes of AbbVie, Novo Nordisk, Pfizer and more ... Fierce Biotech’s James Waldron and Gabrielle Masson discuss the entries that stood out for them ...
Attorney General Pam Bondi has curtailed Justice Department anti-corruption efforts, ratcheted up immigration enforcement and ...
Have landlords turned a corner after years of mostly empty offices? City Center Group, which is downtown Allentown’s largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results